FIELD: chemistry.
SUBSTANCE: present invention relates to new imidazole derivatives of general formula I 
, where R1 is C1-C10alkyl or C3-C10cycloalkyl, each possibly and independently substituted with 1 substitute selected from C3-C10cycloalkyl or aryl or a heteroaryl group, possibly substituted with one or two halogens; aryl or heteroaryl; R2 is C1-C10alkoxy or C1-C10thioalkyl; R3 is C1-C10alkoxy, possibly substituted with one C1-C10alkoxy or nitrile, where the said alkoxy group can be cyclic or can contain one O heteroatom; R4 is C1-C10alkyl; C2-C10alkenyl; C1-C10alkoxy or C3-C10cycloalkyl, each possibly and independently substituted with 1 or 2 substitutes selected from C1-C10alkoxy, C3-C10cycloalkyl, carboxylic ester, or with one or two aryl or heteroaryl groups, possibly substituted with one substitute selected from C1-C10alkyl, C3-C10cycloalkyl, nitro or halogen; aryl or heteroaryl, each possibly and independently substituted with 1-3 substitutes selected from C1-C10alkyl, C3-C10cycloalkyl, C1-C10alkoxy, phenoxy, thiophenyl, halogen, nitro, nitrile or aryl group, possibly substituted with one halogen; where up to three hydrogen atoms of the alkyl group can be substituted with fluorine atoms; where the said cycloalkyl can independently have one or two carbon atoms substituted with O or N; where the said aryl denotes an aromatic ring having 6 to 10 carbon atoms, including mono- and bicyclic compounds; and where the said heteroaryl denotes an aromatic ring having 3 to 10 carbon atoms, including mono- and bicyclic compounds in which one to three ring atoms are oxygen, nitrogen or sulphur atoms; except compounds given in paragraph 1. The invention also pertains to use of the said compounds for making a medicinal agent, a treatment and prevention method, a compound of formula II 
(values of radicals are given in the formula of invention).
EFFECT: new imidazole derivatives having positive allosteric modulator effect on GABAB receptor are obtained.
30 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INHIBITION OF RAF KINASE-MEDIATED GROWTH OF TUMOR CELLS, HETEROCYCLIC UREA DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS) | 1998 |
|
RU2232015C2 |
| COMBINATIONS OF GLUCOPYRROLATE AND B-2 ADRENOCEPTOR ANTOGONISTS | 2005 |
|
RU2388465C2 |
| ARYL- AND HETEROARYL-SUBSTITUTED HETEROCYCLIC DERIVATIVES OF UREA, METHOD FOR INHIBITION OF RAF KINASE ACTIVITY AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2265597C2 |
| PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
| N-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITOR | 2003 |
|
RU2307831C9 |
| 5-HYDROXYBENZOTHIAZOLE DERIVATIVES AS β-ADRENORECEPTOR AGONISTS | 2005 |
|
RU2402540C2 |
| 2-SUBSTITUTED 4,5-DIARYLIMIDAZOLES, METHOD FOR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2214408C2 |
| N3-ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS | 2003 |
|
RU2300528C2 |
| ENANTIOSELECTIVE METHOD FOR SYNTHESIS OF QUINOLINE DERIVATIVES | 2005 |
|
RU2383534C2 |
| USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS | 2010 |
|
RU2600869C2 |
